newsfilter
← Latest News
GlobeNewswire·

DICE Therapeutics to Participate at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (NASDAQ:DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral